Maxime Dely: Platelet Agitation Strengthens Quality and Confidence in Transfusion Medicine
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
”Platelet concentrate agitation: a technical detail that saves lives
In transfusion medicine, clinical performance begins long before administration. It starts with storage conditions.
Platelet concentrates are stored at 20–24°C under continuous agitation. This is not a logistical choice, but a physiological one. Platelets are living, metabolically active cells: they consume oxygen, produce CO₂, and generate metabolites.
Without agitation, gas exchange decreases, pH drops, metabolism is altered, and hemostatic function deteriorates. Ultimately, this affects cell viability and transfusion efficacy.
Gentle, continuous agitation optimizes oxygenation, limits CO₂ accumulation, and helps maintain biochemical parameters compatible with optimal platelet function.
This measure directly contributes to risk control, both infectious and functional, and therefore to patient safety.
In transfusion medicine, scientific rigor is never optional. Every controlled parameter strengthens quality, safety, and confidence in the transfusion process.
Because behind every platelet concentrate, there is a patient who matters.”
Patricia Epstein, Head of the Hemotherapy Division at Hospital Gral de Agudos “Dr. Carlos G. Durand” and Head of Service at Hospital General de Agudos Juan A. Fernandez, shared this post, adding:
”All points of the process make up the final product, as in any production line….. details matter!!!”
Proceed to the video attached to the post.
Find more posts featuring Maxime Dely on Hemostasis Today.
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
-
May 23, 2026, 16:24Marc Wittwer: A Practical Viscoelastic-Guided Algorithm for Trauma-Induced Coagulopathy in Clinical Workflow